
LifeMD (LFMD) Stock Forecast & Price Target
LifeMD (LFMD) Analyst Ratings
Bulls say
LifeMD Inc. has demonstrated notable growth momentum through its weight management program, which has been a key driver of revenue increase in recent quarters. The company is expected to accelerate growth in 2025, supported by its comprehensive telehealth platform that integrates various healthcare services and products. Additionally, the introduction of direct access to Wegovy at a significantly reduced cost could attract more subscribers, further enhancing topline sales for the company.
Bears say
LifeMD Inc. faces significant financial uncertainties that contribute to a negative outlook, primarily due to its reliance on the Telehealth segment for revenue. Key risks include potential lower growth in telehealth revenue, challenges in acquiring and retaining patients, and the company's struggle to achieve profitability amid increasing competition. Additionally, concerns regarding net debt and preferred stock further complicate the financial landscape, indicating possible dilution risks that may affect investor confidence.
This aggregate rating is based on analysts' research of LifeMD and is not a guaranteed prediction by Public.com or investment advice.
LifeMD (LFMD) Analyst Forecast & Price Prediction
Start investing in LifeMD (LFMD)
Order type
Buy in
Order amount
Est. shares
0 shares